Cell Bio 2012 event brims with biophotonics innovations

Seemingly well-timed in the midst of the 2012 holiday season, the American Society for Cell Biology (ASCB)'s annual meeting, held December 15-19, 2012, in San Francisco, CA, this year, had a lot to give to its some-7,000 attendees through its exhibition, symposia, and poster presentations. While not solely a bio-optics and biophotonics event, the innovations for these markets present on the exhibit floor, etc., didn't disappoint.

A handful of companies had chosen ASCB as their venue to unveil some of their latest innovations in this space. Here are a couple of note:

At Bio-Rad Laboratories' (Hercules, CA) booth, the company showed its S3 Cell Sorter, "the first truly walk-up automated cell sorter available," they claim, as scientists need minimal training to operate it. Equipped with one or two lasers and up to four fluorescence detectors, the benchtop system has fully enclosed fluidics and temperature control in a 2.3 x 2.1 x 2.1 ft footprint. What's more, the system is ready to sort samples in less than 30 minutes for high-throughput applications such as polymerase chain reaction (PCR) and fluorescent cell imaging.

Scientific instrumentation maker FEI (Hillsboro, OR) launched a light/electron microscopy combo that enables scientists to see structural and functional relationships at various resolutions in their samples with unprecedented detail, says the company. The iCorr fluorescence microscope module, which is available either as an integrated component on the company's Tecnai transmission electron microscopes or as as a retrofitted module on already installed Tecnai platforms, delivers correlative results in minutes rather than hours or days, thanks to a white-light LED source and image acquisition at 10 fps.

For BioOptics World's full report on the event, please stay tuned for the January/February 2013 issue. Until then, have a wonderful New Year!

Take 10 minutes now

What if just 10 minutes could make a big difference? This is Science Advocacy Week (October 1-5, 2012), when your 10 minutes, added to my 10 minutes, added to 10 minutes from scientists across the nation adds up to a spotlight on bio-optics in particular, and science in general.

Not everyone understands how important basic research is--a fact that is unfortunate at best and, in the case of elected officials, potentially devastating. This week presents a great opportunity to heighten the profile of your work and its impact. 

Next week the news media will report the 2012 Nobel Prizes in science, and when President Obama’s correspondence office staff sorts through incoming messages to pass along to the president, they look for examples that are timely, compelling, and representative of topics in the news (according to Mike Kelleher, former director of that office). So the timing's perfect; let’s do what we can to see that science topics dominate the in boxes of our elected officials this week.  

A nice page on the congress.org website makes it super easy to send the same message to all of your federal lawmakers at once. Very cool!  

When composing your message, keep in mind that just last month, lawmakers heard highlights from the NRC’s new Optics & Photonics: Essential Technologies for Our Nation report, which discussed the importance of these technologies in life sciences among many other areas.    

Also keep in mind these tips, drawn from congress.org:
o  Be polite.
o  Keep it short and accessible to laymen, and write to the interests of those who will read it.
o  Be personable, be yourself.
o  Don’t be shy, don’t use all caps.
o  Contact only your own lawmakers (using this link ensures you will), and make it clear at the top of your message that you are a constituent

I always like to give to charity when there’s an opportunity for matching donations, and I think this week’s advocacy campaign amounts to about the same thing in the interests of science. Let’s add our voices to those of the American Society for Cell Biology and the and the Genetics Society of America. Please join me in going to bat for bio-optics.

Drexler webcast looks at future of OCT

I'm excited that today (Monday, October 17) at 3 pm ET, Wolfgang Drexler, one of the scientists who pioneered optical coherence tomography (OCT) will deliver online his presentation that drew a standing room-only audience at the 2011 Laser World of Photonics event. Fasten your seatbelt--this is a fast-paced ride through the key technological and market developments that brought us to where we are today, and that portend the future of OCT and how it will likely impact medical imaging for a range of specialties.

Dr. Drexler is the Director of the Center for Medical Physics and Biomedical Engineering, Medical University Vienna in Vienna, Austria.

Register now for the webcast so that even if you can't make it to the live event, you'll receive a link to the archive once it is posted: click here.

According to the report "Optical Coherence Tomography 2010: Technology, Applications, and Markets" by Strategies Unlimited, the global market for OCT grew from less than $10 million in 2001 to more than $275 million in 2009. By 2012 the market is expected to reach nearly $800 million.

Biomedical keynotes highlight top growth areas at Laser World of Photonics 2011

Laser World of Photonics 2011 definitely seemed larger than the 2009 event--and the final tally confirmed that indeed it was. The top two growth areas were medical technology and biophotonics, according to Messe Muenchen GmbH; this year’s conference and exhibition attracted not only 8% more visitors (for a total of 27,500) but also a record number of exhibitors (1100).

The event celebrated the 20th anniversary of optical coherence tomography (OCT) with a CLEO Europe and European Conference on Biomedical Optics (ECBO) co-sponsored technology and applications tutorial by OCT pioneer Jim Fujimoto. The MIT professor drew a standing-room-only crowd; so did the two ECBO plenary talks. One, by another OCT powerhouse, Wolfgang Drexler of the Medical University of Wein (Austria), whisked audience members through OCT history highlights, and painted an enthusiastic picture of future technology and market development.

The other ECBO plenary featured Prof. Mary-Ann Mycek of the University of Michigan (USA) discussing an optical spectroscopy technique that offers exciting promise for early detection of pancreatic cancer.

Report from Biomedical Optics Symposium (BiOS)/Photonics West--Part 2

Even though it most definitely exists, “the cost benefit of most clinical biophotonics technology is not well documented,” said Brian C. Wilson (Department of Medical Biophysics, University of Toronto) in his informative presentation during Monday's Lasers and Photonics Marketplace Seminar.

Even though it most definitely exists, “the cost benefit of most clinical biophotonics technology is not well documented,” said Brian C. Wilson (Department of Medical Biophysics, University of Toronto) in his informative presentation during Monday's Lasers and Photonics Marketplace Seminar.

On Tuesday, two plenary sessions took place: Frances S. Ligler, the Navy’s Senior Scientist for Biosensors and Biomaterials and current Chair of the Bioengineering Section of the National Academy of Engineering, presented a Perspective on the Future of Optical Biosensors. And Harold G. Craighead, Director of the Nanobiotechnology Center at Cornell University, explored the use of nanostructures for biological research.

Neuroscience loves biooptics!

Normally, perusing the conference program is a good way to tell whether a trade show is a good match for your interests. If your interests are in biooptics and biophotonics, though, looking at the Neuroscience 2008 (Washington, DC, November 15-19) program would not have been a reliable indicator of relevance. There was nary a mention of technologies in the session descriptions—but the show floor was positively bursting with photonics and optics companies, both component suppliers and instrumentation vendors. That’s certainly not true of all biomedical industry events, so I was pleasantly surprised.

Normally, perusing the conference program is a good way to tell whether a trade show is a good match for your interests. If your interests are in biooptics, though, looking at the Neuroscience 2008 (Washington, DC, November 15-19) program would not have been a reliable indicator of relevance. There was nary a mention of technologies in the session descriptions—but the show floor was positively bursting with photonics and optics companies, both component suppliers and instrumentation vendors. That’s certainly not true of all biomedical industry events, so I was pleasantly surprised.

My picks for show highlights:

Lockheed Martin Aculight, which promoted its Capella infrared nerve stimulator.

Olympus showcased its FSX100 Bio Imaging Navigator all-in-one microscope system among other products that address both ends of the microscopy spectrum and cater to either the high-end user or novice microscopists.

Carl Zeiss MicroImaging made a splash by announcing four new fluorescence imaging systems, saying these additions make its family of optical sectioning microscopes the largest on the market. Zeiss also used Neuroscience 2008 to launch an educational website in collaboration with Florida State University, which intends to be a "comprehensive and independent resource to learn about the latest techniques in fluorescence imaging."

Both Zeiss and Visage Imaging showcased software working on autostereoscopic (meaning no need for red-and-blue glasses or other eyewear/headgear!) interactive 3D displays by Tridelity, which uses a parallax barrier to produce a two-view, head-tracked display for single-viewer systems or a multiview display that supports multiple viewers.

And Nikon and Thorlabs announced their collaboration to bring optical coherence tomography (OCT) to Nikon's FN1 "PhysioStation" microscope system for neurophysiology and in vivo, small-animal studies.

More information:
Tridelity